(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EPIZON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

EPIZON

ST13

US500000086984319

Class

5

Filing

86984319

Registration

5692098

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

07/02/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

11/17/2015

Registration date

03/05/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/31/2025

Last transaction

07/02/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/30/2018

First use in commerce

07/30/2018

Drawing code

3

Owner type

03

Owner location

Orange, CT, US

Examiner

POWELL, LINDA

Current location

Historical data usage

Mark description

The mark consists of the word "EPIZON" featuring a benzene ring as the "O".

Holders and representatives

Holders

Epizon Pharma, Inc.
Epizon Pharma, Inc.

Representatives

Alexander P. Montgomery Hinckley, Allen & Snyder, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the treatment of vascular diseasecardiovascular diseaseheart diseaseosteoporosisbone diseaserenal diseasekidney diseaseautoimmune diseaseatherosclerosisexcluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactionsanaphylaxisasthma and pharmaceuticals for the treatment of allergic reactionanaphylaxis or asthma

Publications

History of USPTO decisions and trademark events.

54 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/01/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/01/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/01/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/01/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/01/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/31/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/31/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/31/2025

E815

TEAS SECTION 8 & 15 RECEIVED

09/13/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

03/05/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/31/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/30/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/04/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/03/2019

DPCC

DIVISIONAL PROCESSING COMPLETE

01/03/2019

IUAF

USE AMENDMENT FILED

12/19/2018

DRRR

DIVISIONAL REQUEST RECEIVED

12/19/2018

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

12/19/2018

EISU

TEAS STATEMENT OF USE RECEIVED

12/19/2018

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/29/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/29/2018

EX3G

SOU EXTENSION 3 GRANTED

05/25/2018

EXT3

SOU EXTENSION 3 FILED

05/25/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/25/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/29/2017

EX2G

SOU EXTENSION 2 GRANTED

11/27/2017

EXT2

SOU EXTENSION 2 FILED

11/27/2017

EEXT

SOU TEAS EXTENSION RECEIVED

11/27/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/02/2017

EX1G

SOU EXTENSION 1 GRANTED

05/31/2017

EXT1

SOU EXTENSION 1 FILED

05/31/2017

EEXT

SOU TEAS EXTENSION RECEIVED

05/31/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/31/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/05/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/01/2017

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/11/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/27/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/01/2016

PUBO

PUBLISHED FOR OPPOSITION

11/01/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/12/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/26/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/20/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/01/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/01/2016

ALIE

ASSIGNED TO LIE

08/25/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/19/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/11/2016

GNRT

NON-FINAL ACTION E-MAILED

03/11/2016

CNRT

NON-FINAL ACTION WRITTEN

03/11/2016

DOCK

ASSIGNED TO EXAMINER

03/09/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/21/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/20/2015

NWAP

NEW APPLICATION ENTERED

11/20/2015

Continuous trademark protection

Get notified about every new filing that threatens EPIZON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.